Mechanisms of the anabolic effects of teriparatide on bone: Insight from the treatment of a patient with pycnodysostosis

Journal of Bone and Mineral Research

Volumn 23, Issue 7, 2008, Pages 1076-1083

  Chavassieux, Pascale ^a,c   Karsdal, Morten Asser ^b   Segovia Silvestre, Toni ^b   Neutzsky Wulff, Anita V ^b   Chapurlat, Roland ^a   Boivin, Georges ^a   Delmas, Pierre D ^a  

^a UNIVERSITÉ DE LYON   (France)

^b NORDIC BIOSCIENCE A S   (Denmark)

^c INSERM   (France)

Author keywords

Bone turnover; Cathepsin K; Osteosclerosis; Pycnodysostosis; Teriparatide

Indexed keywords

AMINO TERMINAL TELOPEPTIDE; ANABOLIC AGENT; BIOCHEMICAL MARKER; CARBOXY TERMINAL TELOPEPTIDE; CATHEPSIN K; CD14 ANTIGEN; DEOXYPYRIDINOLINE; OSTEOCALCIN; PARATHYROID HORMONE[1-34];

ADULT; AMINO ACID SUBSTITUTION; ARTICLE; BONE BIOPSY; BONE FRAGILITY; BONE MINERALIZATION; BONE REMODELING; BONE STRUCTURE; BONE TURNOVER; CASE REPORT; CELL DIFFERENTIATION; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; DISEASE SEVERITY; DRUG MECHANISM; DRUG POTENCY; FEMALE; FRAGILITY FRACTURE; GENE SEQUENCE; HUMAN; HUMAN CELL; HUMAN TISSUE; IN VITRO STUDY; IN VIVO STUDY; MICRORADIOGRAPHY; MISSENSE MUTATION; MONOCYTE; NUCLEOTIDE SEQUENCE; OSSIFICATION; OSTEOBLAST; OSTEOLYSIS; OSTEOPOROSIS; OSTEOSCLEROSIS; PHENOTYPE; PYKNODYSOSTOSIS; QUALITATIVE ANALYSIS; QUANTITATIVE ANALYSIS; RARE DISEASE; SHORT STATURE; SKULL MALFORMATION; THORAX MALFORMATION;

ADULT; ANABOLIC AGENTS; BONE AND BONES; CATHEPSINS; DYSOSTOSES; FEMALE; HUMANS; TERIPARATIDE;

EID: 46249121353     PISSN: 08840431     EISSN: None     Source Type: Journal    
DOI: 10.1359/jbmr.080231     Document Type: Article

References (49)

1. Littlewood-Evans A, Kobuto T, Ishibashi O, Inaoka T, Wlodarski B, Gallagher JA, Bilbe G 1997 Localization of cathepsin K in human osteoclasts by in situ hybridization and immunohistochemistry. Bone 20:81-86.
2. Whyte MP 2003 Genetic, developmental and dysplastic skeletal disorders. In: Favus MJ (ed.) Primer on the Metabolic Bone Diseases and Disorders of Mineral Metabolism, 5th ed. American Society for Bone and Mineral Research, Washington, DC, USA, pp. 449-466.
3. Gowen M, Lazner F, Dodds R, Kapadia R, Field J, Tavaria M, Bertoncello J, Drake F, Zavarselk S, Tellis I, Hertzog P, Debouk C, Kola J 1999 Cathepsin K knockout mice develop osteopetrosis due to a deficit in matrix degradation but not demineralization. J Bone Miner Res 14:1645-1663.
4. Neer RM, Arnaud CD, Zanchetta JR, Prince R, Gaich GA, Reginster JY, Hodsman AB, Eriksen EF, Ish-Shalom S, Genant HK, Wang O, Mitlak BH 2001 Effect of parathyroid hormone (1-34) on fractures and bone mineral density in postmenopausal women with osteoporosis. N Engl J Med 344:1434-1441.
5. Garnero P, Grimaux M, Demiaux B, Preaudat C, Seguin P, Delmas PD 1992 Measurements of serum osteocalcin with a human specific two-site immunoradiometric assay. J Bone Miner Res 7:1389-1398.
6. Garnero P, Sornay-Rendu E, Claustrat B, Delmas PD 2000 Biochemical markers of bone turnover, endogenous hormones and the risk of fractures in postmenopausal women: The OFELY study. J Bone Miner Res 15:1526-1536.
7. Garnero P, Borel O, Delmas PD 2001 Evaluation of a fully automated serum assay for C-terminal cross-linking telopeptide of type I collagen in osteoporosis. Clin Chem 47:694-702.
8. Uebelhart D, Gineyts E, Chapuy MC, Delmas PD 1990 Urinary excretion of pyridinium crosslinks: A new marker of bone resorption in metabolic bone disease. Bone Miner 8:87-96.
9. Garnero P, Delmas PD 2003 An immunoassay for type I collagen alpha 1 helicoidal peptide 620-633, a new marker of bone resorption in osteoporosis. Bone 32:20-26.
10. Boutroy S, Bouxsein ML, Munoz F, Delmas PD 2005 In vivo assessment of trabecular bone microarchitecture by high-resolution peripheral quantitative computed tomography. J Clin Endocrinol Metab 90:6508-6515.
11. Parfitt AM, Mathews CH, Villanueva AR, Kleerekoper M, Frame B, Rao DS 1983 Relationships between surface, volume and thickness of iliac trabecular bone in aging, and in osteoporosis. Implications for the microanatomic and cellular mechanisms of bone loss. J Clin Invest 72:1396-1409.
12. Chavassieux P, Arlot M, Meunier PJ 2001 Clinical use of bone biopsy In: Marcus R, Feldman D, Kelsey J (eds.) Osteoporosis, 2nd ed. Academic Press, San Diego, CA, USA, pp. 501-512.
13. Parfitt AM, Drezner MK, Glorieux F, Kanis JA, Malluche H, Meunier PJ, Ott SM, Recker RR 1987 Bone histomorphometry: Standardization of nomenclature, symbols, and units. Report of the ASBMR Histomorphometry Nomenclature Committee. J Bone Miner Res 2:595-610.
14. Boivin G, Meunier PJ 2002 The degree of mineralization of bone issue measured by computerized quantitative contact microradiography. Calcif Tissue Int 70:503-511.
15. Sorensen MG, Henriksen K, Schaller S, Henriksen DB, Mielsen FC, Dziegiel MH, Karsdal MA 2007 Characterization of osteoclasts derived from CD14+ monocytes isolated from peripheral blood. J Bone Miner Metab 25:36-45.
16. Karsdal MA, Hjorth P, Henriksen K, Kirkegaard T, Nielsen KL, Lou H, Delaisse JM, Foged NT 2003 Transforming growth factor-beta controls human osteoclastogenesis through the p38 MAPK and regulation of RANK expression. J Biol Chem 278:44975-44987.
17. Rehman MTA, Hoyland JA, Denton J, Freemont AJ 1974 Age related histomorphometric changes in bone in normal British men and women. J Clin Pathol 47:529-534.
18. Vedi S, Compston JE, Webb A, Tighe JR 1983 Histomorphometric analysis of dynamic parameters of trabecular bone formation in the iliac crest of normal British subjects. Metab Bone Dis Relat Res 5:69-74.
19. Fratzl-Zelman N, Valenta A, Roschger P, Nader A, Gelb BD, Fratzl P, Klaushofer K 2004 Decreased bone turnover and deterioration of bone structure in two cases of pycnodysostosis. J Clin Endocrinol Metab 89:1538-1547.
20. Beneton M, Harris S, Kanis JA 1987 Paramyxovirus-like inclusions in two cases of pycnodysostosis. Bone 8:211-217.
21. Everts V, Aronson DC, Beertsen W 1985 Phagocytosis of bone collagen by osteoclasts in two cases of pycnodysostosis. Calcif Tissue Int 37:25-31.
22. Everts V, Delaissé JM, Korper W, Jansen DC, Tigchelaar-Gutter W, Saftig P, Beertsen W 2002 The bone lining cell: Its role in cleaning Howship's lacunae and initiating bone formation. J Bone Miner Res 17:77-90.
23. Nishi Y, Atley L, Eyre DE, Edelson JG, Superti-Furga A, Yasuda T, Dresnick RJ, Gelb BD 1999 Determination of bone markers in pycnodysostosis: Effects of cathepsin K deficiency on bone matrix degradation. J Bone Miner Res 14:1902-1908.
24. Garnero P, Borel O, Byrjalsen I, Ferreras M, Drake FH, McQueney MS, Foged NT, Delmas PD, Delaisse JM 1998 The collagenolytic activity of cathepsin K is unique among mammalian proteinase. J Biol Chem 273:32347-32352.
25. Boivin G, Meunier PJ 2002 Changes in bone remodelling rate influence the degree of mineralization of bone. Connect Tissue Res 43:535-537.
26. Seeman E, Delmas PD 2006 Bone quality: The material and structural basis of bone strength and fragility. N Engl J Med 354:2250-2261.
27. Chavassieux P, Seeman E, Delmas PD 2007 Insights into material and structural basis of bone fragility from diseases associated with fractures: How determinants of the biomechanical properties of bone are compromised by disease. Endocr Rev 28:151-164.
28. Schilling AF, Mülhausen C, Lehman W, Santer R, Schinke T, Rueger JM, Amling M 2007 High bone mineral density in pycnodysostotic patients with a novel mutation in the propeptide of cathepsin K. Osteoporos Int 18:659-669.
29. Li CY, Jepsen KJ, Majeska RJ, Ni R, Gelb BD, Schaffler MB 2006 Mice lacking cathepsin K maintain bone remodeling but develop bone fragility despite high bone mass. J Bone Miner Res 21:865-875.
30. Fujita Y, Nakata K, Yasui N, Matsui Y, Kataoka E, Horoshima K, Shiba RT, Ochi T 2000 Novel mutations of the cathepsin K gene in patients with pycnodysostosis and their characterization. J Clin Endocrinol Metab 85:425-431.
31. Hou WS, Bromme D, Zhao Y, Mehler E, Dushey C, Weinstein H, Miranda CS, Fraga C, Greig F, Carey J, Rimoin DL, Desnick RJ, Gelb BD 1999 Characterization of novel cathepsin K mutations in the pro and mature polypeptide regions causing pycnodysostosis. J Clin Invest 103:731-738.
32. Dempster DW, Cosman F, Kurland ES, Zhou H, Nieves J, Woelfert L, Shane E, Plavetic K, Muller R, Bilezikian J, Lindsay R 2001 Effects of daily treatment with parathyroid hormone on bone microarchitecture and turnover in patients with osteoporosis: A paired biopsy study. J Bone Miner Res 16:1846-1853.
33. Misof BM, Roschger P, Cosman F, Kurland ES, Tesch W, Messmer P, Dempster DW, Nieves J, Shane E, Fratzl P, Klaushofer K, Bilezikian J, Lindsay R 2003 Effects of intermittent parathyroid hormone administration on bone mineralization density in iliac crest biopsy from patients with osteoporosis: A paired study before and after treatment. J Clin Endocrinol Metab 88:1150-1156.
34. Arlot MA, Meunier PJ, Boivin G, Haddock L, Tamayo J, Correa-Rotter R, Jasquis S, Donley DW, Dalsky GP, San Martin J, Eriksen EF 2005 Differential effects of teriparatide and alendronate on bone remodeling in postmenopausal women assessed by histomorphometric parameters. J Bone Miner Res 20:1244-1253.
35. Lindsay R, Cosman F, Zhou H, Bostrom MP, Shen VW, Cruz JD, Nieves JW, Dempster DW 2006 A novel tetracycline labeling schedule for longitudinal evaluation of the short-term effects of anabolic therapy with a single iliac crest bone biopsy: Early actions of teriparatide. J Bone Miner Res 21:366-373.
36. Jilka RL, Weinstein RS, Bellido T, Roberson P, Parfitt AM, Manolagas SC 1999 Increased bone formation by prevention of osteoblasts apoptosis with parathyroid hormone. J Clin Invest 104:439-446.
37. Deal C, Omizo M, Schwartz EN, Eriksen EF, Cantor P, Wang J, Glass EV, Myers SL, Krege JH 2005 Combination teriparatide and raloxifene therapy for postmenopausal osteoporosis; results from a 6-month double-blind placebo-controlled trial. J Bone Miner Res 20:1905-1911.
38. Delmas PD, Vergnaud P, Arlot MA, Pastoureau P, Meunier PJ, Nilssen MHL 1995 The anabolic effect of human PTH(1-34) on bone formation is blunted when bone resorption is inhibited by the bisphosphonate tiludronate - Is activated resorption a prerequisite for the in vivo effect of PTH on formation in a remodeling system? Bone 16:603-610.
39. Black DM, Greenspace SL, Ensrud KE, Palermo L, McGowan JA, Lang TF, Garnero P, Bouxsein ML, Bilezikian JP, Rosen CJ 2003 The effects of parathyroid hormone and alendronate alone or in combination on postmenopausal osteoporosis. N Engl J Med 349:1207-1215.
40. Hodsman A, Steer B 1993 Early histomorphometric changes in response to parathyroid hormone therapy in osteoporosis: Evidence for de novo bone formation on quiescent cancellous bone surfaces. Bone 14:523-527.
41. Karsdal MA, Martin TJ, Bollerslev J, Christiansen C, Henriksen K 2007 Are non resorbing osteoclasts sources of bone anabolic activity? J Bone Miner Res 22:487-494.
42. Lian JB, Marks SC Jr 1990 Osteopetrosis in the rat: Coexistence of reduction in osteocalcin and bone resorption. Endocrinology 126:955-962.
43. Demiralp B, Chen HL, Koh AJ, Keller ET, McCauley LK 2002 Anabolic actions of parathyroid hormone during bone growth are dependent on c-fos. Endocrinology 143:4038-4047.
44. Kornack U, Kasper D, Bosl MR, Kaiser E, Schweizer M, Schulz A, Friedrich W, Delling G, Jentsch TJ 2001 Loss of the ClC-7 chloride channel leads to osteopetrosis in mice and man. Cell 104:205-215.
45. Li YP, Chen W, Liang Y, Li E, Stashneko P 1999 Atp6i-deficient mice exhibit severe osteopetrosis due to loss of osteoclast-mediated extracellular acidification. Nat Genet 23:447-451.
46. Martin TJ 2004 Does bone resorption inhibition affect the anabolic response to parathyroid hormone? Trends Endocrinol Metab 15:49-50.
47. Koh AJ, Demiralp B, Neiva KG, Hooten J, Nohutcu RM, Shim H, Datta NS, Taichman RS, Mc Cauley LK 2005 Cells of the osteoclast lineage as mediators of the anabolic actions of parathyroid hormone in bone. Endocrinology 146:4584-4596.
48. Jones SJ, Gray C, Boyde A 1994 Simulation of bone resorption-repair coupling in vitro. Anat Embryol (Berl) 190:339-349.
49. Gray C, Boyde A, Jones SJ 1996 Topographically induced bone formation in vitro: Implications for bone implants and bone grafts. Bone 18:115-123.